Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

NCT04734210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: 0.02% Betamethasone Sodium Phosphate
DRUG: 0.04% Betamethasone Sodium Phosphate
DRUG: Placebo

Sponsor

Surface Ophthalmics, Inc.